Extracorporeal Membrane Oxygenation Machine Market Share

Asia Pacific Market Statistics

The extracorporeal membrane oxygenation machine market in the Asia Pacific region is projected to hold the largest revenue\ share of 36% by the end of 2037. Collaborations and partnerships among the extracorporeal membrane oxygenation machine manufacturers and local healthcare institutions in the region are promoting technology transfer in different countries.

On top of that, these collaborations enhance the accessibility of advanced extracorporeal membrane oxygenation machine technologies and ensure that the region benefits from the latest developments in the medical field. India has one of the world's largest insurance schemes named the Ayushman BharatPradhan Mantri Jan Aroya Yojana launched in 2017 is poised to meet the universal health requirements and achieve sustainable development goals.

Such schemes play very pivotal role in lifting the medical sector and advance equipment including extracorporeal membrane oxygenation machine. The market in the region is further witnessing robust growth driven by factors such as the increasing incidence of respiratory diseases, initiatives by the government, and advancements in healthcare infrastructure.

North American Market Analysis

The ECMO machine market in the North American region is projected to hold the second largest share during the projection period 2024-2037. The region encounters a high prevalence of cardiovascular diseases that contribute significantly to the demand for extracorporeal membrane oxygenation machine. Also, conditions such as severe heart failure and post-cardiotomy shock require necessary advanced life support for the patient and extracorporeal membrane oxygenation machine emerges as a vital intermediate in managing these critical cases effectively. The region is a hub for technological advancements in healthcare.

According to the New York State Department of Health, nearly 0.7 million people die due to heart disorders or strokes every year. Therefore, the market benefits from a high number of deaths happening due to heart diseases, and continuous advancements, like improved membrane materials, enhanced pump technologies, and sophisticated monitoring systems. These supreme innovations in healthcare contribute to the efficiency, safety, and effectiveness of extracorporeal membrane oxygenation machine therapy.